| Literature DB >> 30985089 |
Fei Gao1, Wensheng Xie2, Yuqing Miao1, Dan Wang2, Zhenhu Guo2, Anujit Ghosal1, Yongsan Li3, Yen Wei3, Si-Shen Feng4, Lingyun Zhao2, Hai Ming Fan1.
Abstract
Engineering biocompatible hydrogels using functional nanoparticles has attracted considerable attention because of their uniquely appealing cooperative effects that can enable multimodality imaging and treatment with improved efficacy against serious diseases. However, the effects of high-content nanoparticle dopants on the rheological properties of hydrogels frequently lead to an unsatisfactory therapeutic result, which is particularly notable in the design of magnetic hydrogel formulations for cancer therapy. Herein is reported a novel magnetic hydrogel functionalized by ferromagnetic vortex-domain iron oxide (FVIOs) with optimally adaptive functions for prevention of breast cancer recurrence. The FVIOs can perfectly incorporate into the dynamic hydrogel networks with an extremely low concentration (0.6 mg mL-1 ), 17 times lower than that of conventional superparamagnetic iron oxide nanoparticles with sufficient heating capacity. Such magnetic hydrogels exhibit high inductive heating and remarkable rheological properties simultaneously. Moreover, the self-healing, self-conformal ability, controlled release of loaded doxorubicin, biodegradation, and pH-responsiveness of the magnetic hydrogel project their efficient sustainable therapeutic ability. In vivo postoperative treatment has further demonstrated the high efficacy of FVIO-based magnetic hydrogels, as evidenced by the significant suppression of the local tumor recurrences compared to chemotherapy or hyperthermia alone. This unique magnetic hydrogel formulation with optimally adaptive functions shows strong potential in preventing relapses of various cancers.Entities:
Keywords: adaptive function; breast cancer recurrence; ferromagnetic vortex-domain iron oxide nanorings (FVIOs); induction heat; magnetic hydrogels
Year: 2019 PMID: 30985089 DOI: 10.1002/adhm.201900203
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933